D

DOCMODE HEALTH TECH LTD

DHTLNSE
Market snapshot · 2026-08-11 06:22 UTC

33.25

₹-1.75 (-5.00%)

MARKET CAP

STOCK P/E

52W HIGH

₹33.25

52W LOW

₹33.25

BOOK VALUE

EPS

ROE

SECTOR

Healthcare

DEBT/EQUITY

VOLUME

800

P/B RATIO

PEG RATIO

Sector

Healthcare

Themes

Healthcare
₹34.25₹34.00₹33.75₹33.50₹33.25VolumeAug '26

AI Summary

✦ Clartha

Forecast

Analyst targets, estimate history, and probabilistic forward ranges for DHTL.

Coverage check

Price Forecast

Current
₹33.25
High Target
Median Target
Low Target
Price history (1Y)
Analyst target range

Probabilistic Range

Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.

Time horizonRange ()Probability
3M₹20.78 - ₹40.1380%
6M₹15.75 - ₹39.9580%
12M₹9.80 - ₹36.5480%
Realized vol: +51.4% · Drift: -43.2%

Revenue Forecast

₹ Cr
Sep '25Current₹18.0
Sep 2026 ETrend estimate range
High₹17.5Base₹16.2Low₹14.9
Mar '24: ₹16.0 · Sep '24: ₹20.0 · Mar '25: ₹21.0 · Sep '25: ₹18.0 · Sep '26: ₹16.2 · Dec '26: ₹16.2
Mar '24Sep '24Mar '25Sep '25Sep '26 EDec '26 E16.020.021.018.016.216.2
PastCurrentTrend estimate: Low / Base / High

EPS Forecast

₹ / share
Sep '25Current₹-0.29
Sep 2026 ETrend estimate range
High₹-0.23Base₹-0.20Low₹-0.18
Mar '24: ₹-3.72 · Sep '24: ₹-1.65 · Mar '25: ₹-4.80 · Sep '25: ₹-0.29 · Sep '26: ₹-0.20 · Dec '26: ₹-0.20
Mar '24Sep '24Mar '25Sep '25Sep '26 EDec '26 E-3.72-1.65-4.80-0.29-0.20-0.20
PastCurrentTrend estimate: Low / Base / High
Analyst price target unavailable from FMP/yfinance. Analyst recommendation consensus unavailable from FMP/yfinance. Valuation pillar unavailable from supplied valuation. Analyst pillar unavailable from FMP/yfinance.
Market Intelligence

Multi-factor synthesis of 5 key dimensions

Overall Outlook
Cautious
24%
Analyst Consensus
Unavailable

Analyst coverage unavailable

Mean upsideNot available

Fundamentals

Weakening

Fundamentals institutional score is 4 using growth durability 4.5.

Valuation

Unavailable

No valid valuation metrics were supplied.

Analyst Consensus

Unavailable

No usable analyst target or recommendation data was available.

Technical Structure

Weak Structure

Technicals institutional score is 27 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.

Market Sentiment

Neutral backdrop

Recent news flow is balanced or not decisive enough to tilt the tape. Based on 1 recent ticker-linked news items.

Signal Summary

Market intelligence remains Cautious. Available evidence provides partial support, while fundamentals and technical structure remain considerations.

Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.

Fundamentals WeakeningTechnical Structure Weak StructureMarket Sentiment Neutral backdrop

Key Data Points

Mean Target PriceUnavailable
Mean UpsideNot available
Technical Score27%
Fundamental Score5%
Data CoverageMedium

Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

Historical valuation metrics are unavailable for this ticker right now.

Peers & Comparison

Sector: Healthcare

Healthcare Peers8 peers
Avg P/E: 24.6x
CompanyRev. GrowthMarginP/Evs Avg52W Perf.
68.6x
Premium
+179% vs avg
SUNREST.NS,0P0001RTOB,0
SUNRESTHealthcare
7.0x
Undervalued
-72% vs avg
7.3x
Undervalued
-70% vs avg
KRMAYURVED
KRMAYURVEDHealthcare
MEDISTEP
MEDISTEPHealthcare
CURIS
CURISHealthcare
15.4x
Undervalued
-37% vs avg
WHY THESE PEERS

Comparable-scale peer data is limited — showing nearest stored business/industry peers instead of an empty comparison.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹18 CrSep 2025

Latest net profit

₹-0.09 CrSep 2025

Latest EPS

₹-0.29Sep 2025

Net margin

4.5%Sep 2025

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26-3.0%0.0%3.0%6.0%9.0%-8.00 Cr0.00 Cr8.00 Cr16 Cr24 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '260.00 Cr6.00 Cr12 Cr18 Cr24 Cr₹-8₹-6₹-4₹-2₹0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit-6.00 Cr0.00 Cr6.00 Cr12 Cr18 Cr

Latest reported period: Sep 2025

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025-15 Cr0.00 Cr15 Cr30 Cr45 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025
Sales +20.0223.6016.4020.4221.3517.85
Expenses +18.5820.8817.2320.5421.9217.05
Operating Profit1.442.72-0.83-0.12-0.570.80
OPM %7.19%11.53%-5.06%-0.59%-2.67%4.48%
Other Income +0.050.060.070.840.090.07
Interest0.720.840.811.090.820.85
Depreciation0.010.020.010.140.160.11
Profit before tax0.761.92-1.58-0.51-1.46-0.09
Tax %19.74%29.17%-25.95%1.96%4.11%0.00%
Net Profit +0.611.36-1.17-0.52-1.51-0.09
EPS in Rs2.665.93-3.72-1.65-4.80-0.29
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderSep 2024Dec 2024Mar 2025Sep 2025Mar 2026
Promoters47.44%47.44%47.44%30.86%29.50%
Public49.25%50.06%48.97%64.71%65.31%
Others3.31%2.50%3.59%4.43%5.19%
Mar 2026
Promoters
Public
Others

Events Timeline

Amendment to AOA/MOA

Jul 29, 2026PDFCompany Reports Open

Updates

Jul 10, 2026PDFCompany Reports Open

Shareholders meeting

Jul 09, 2026PDFCompany Reports Open

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Jul 09, 2026PDFCompany Reports Open

Shareholders meeting

Jul 08, 2026PDFCompany Reports Open